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Certain findings have been reported suggesting
that materials in tissues from malignant mela-
nomas of human beings can stimulate antibody
formation. Hiramoto and Pressman (1) demon-
strated by the fluorescent-tagged-antibody tech-
nic staining of sections of tumor tissne with anti-
body produced by injecting rabbits with tissue
from human malignant melanoma. However,
these authors found that other cutaneous tissues
also showed affinity for the antibody-fluorescein
conjugates. iViore recently, Blakemore and Mc-
Kenna (2) demonstrated, by the technic of
tanned-red-cell hemagglutination, appearance of
antibodies in the serum of patients with malig-
nant melanoma and a rise in titer of antibodies
when they were injected with extracts of tissue
from malignant melanomas. A number of other
clinical and experimental observations (3—8)
also suggest that materials in tissnc from malig-
nant melanomas can act as antigens.
Using the fluorescent antibody technic we too
studied serologic effects in rabbits injected with
malignant melanoma tissue and other control
substances.
MATERIALS AND METHODS
1. Preparation of antiserums and antigens.—
Tissuet from malignant melanomas, skin, gamma
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globulin and albumin from human beings and
ovalbumin were used in standard immunization
technic in the attempt to provoke antibodies.
Five tumor specimens, three melanotic and twa
amelanotic, were obtained. Surgical or post-mor-
tem specimens of malignant melanoma were
trimmed of fat, weighed and washed with normal
saline until visibly free of blood. The tumor tissue
was wrapped in aluminum foil and dropped into
liquid nitrogen for about one minute. After such
rapid freezing, the specimens were pnlverized by
the method of Wilhelmj et al (9). The material
was stored in small aliquots at _200 C until ready
far use. The tumor tissue was injected into a total
of fifteen rabbits (8 albinos, 7 piebald) of an aver-
age weight of 2.5 kg. Surgical or autopsy specimens
of normal human skin were trimmed of subcutane-
ous fat and processed in the same manner as the
human malignant melanoma specimens. Human
78 gamma globulin was prepared from serum (10).
Human albumin and ovalbumin were purchased.
Each rabbit was bled prior to immunization, at
monthly intervals thereafter and finally one week
after the last injection. The details of the immuni-
zation procedures are listed in Table I.
2. Preparation of .fluorescein-labeled conjugates.
—The 78 gamma globulin portion of the following
serums was isolated and labeled with fluorescein
isothiacyanate (10):
1. Goat antirabbit gamma globulin serums.
2. Pre-immunization serums of rabbits.
3. Post-immunization serums of rabbits.
Unconjugated aliquots of the same preparations
were used for blocking.
3. Preparation of tissue powders for absorption
studies—Autopsy specimens of normal human
kidney, spleen, lung, liver and brain were ob-
tained. These were homogenized in a Virtis ho-
mogenizer at about 45,000 rpm far fifteen minutes.
The suspension was then lyophilized and stored at
—20° C until used.
Whole human blood was separated into plasma
and cells. The plasma and blood cells were lyoph-
ilized separately and stored at —20° C.
Beef liver powder, beef spleen powder, lyophi-
lized human gamma globulin and lyophilized hu-
man albumin were purchasedj.
4. Absorption of rabbit serums with tissue,
plasma and blood cell powders—For every ml of
Pentex Incorporated; Kankakee, Illinois.
§ Antibodies Incorporated, Davis, California.
1 Pentex Incorporated; Kankakee, Illinois.
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TABLE I
Schedules for immunization of rabbits
Antigen injected
Numbee of
rabbits in
each gronp
Major mute ni
immunization
Antigen in Freund's
adjnvant injected
subcutaneously
—(no) +(yes)
Tntal period of
injectinns
Malignant melanoma tissue 10
3
2
Intravenous
Intraperitoneal
Intravenous
—
—
+* 1 to 33 months
1 to 3k months
3j months
Unman skin 2 Intravenous + 3j months
Human 75 gamma globulin 10
2
Intravenous
Intravenous —
+** 1 to 4}' months
2 months
Human albumin 1
2
Intravenous
Intravenous
—
+5*
1 month
1 to 4f.4 months
Ovalbumin 3
3
3
Intravenous
Intraperitoneal
Intravenous
—
—
+k5 2 months
2 months
2 months
Normal saline 4 Intravenous +*** 1 to 3 months
* 14mg of antigen (wet weight) in 0.1 ml of saline mixed with 0.1 ml of complete Freund's adjnvant
(Difco) was injected in the interscapular region once a week f or two weeks. Booster injections contain-
ing 7 mg of antigen in 0.1 ml of normal saline were given intravenously three times a week.
** 10 mg of antigen in 0.1 ml of normal saline mixed with 0.1 ml of complete Freund's adjuvant was
injected in the interscapular region once a week for two weeks. Booster injections of 1.5mg of antigen
were given intravenously three times a week for one week, followed by 2.0mg intravenously three times
a week thereafter.
0.1 ml of normal saline mixed with 0.1 ml of complete Freund's adjuvant was injected in the in-
terscapular area once a week for two weeks. Booster injections of 0.1 ml of normal saline were given
intravenously three times a week.
serum, 200 mg of tissue powder was used. The
powder was resuspended in saline (except in case
of human plasma and blood cell powder) and
centrifuged; the supernatant was discarded and
the wet powder was added to the serum or conju-
gate to be absorbed. Three absorptions were made,
each for one hour at room temperature. The mix-
ture was constantly agitated during this time.
After each absorption the suspension was centri-
fuged at 2500 rpm at 4° C for 20 minutes. The
supcrnatant was removed and added to another
200 mg of wct powder. After the third absorption
the serum or conjugate was used in the staining
procedure.
5. Absorption of rabbit serums with human
gamma globulin or human albumin—For every
ml of serum or conjugate 20 mg of powder was
used. Two absorptions were made for one hour
each at room temperature. After ccntrifugation
the supernatant was removed and 20 mg of fresh
powder was suspended in it. The mixture was kept
at 37° C for one hour and then allowed to stand
overnight at 4° C. After ccntrifugation the super-
natant fluid was used in the staining procedure.
6. Processing of human tissue specimens for
frozen tissue sections—Immediately after excision
the specimens were wrapped in aluminum foil
and dropped into liquid nitrogen for one minute.
Sections two to six microns thick were cut in a
cryostat and placed on glass slides. The sections
were then dried at room temperature for one
hour, fixed in acetone for ten minutes and stored
at —20° C until ready for staining by the fluores-
cent antibody technic. Alternate sections were
stained with hematoxylin and eosin to correlate
light microscopy findings with those of fluores-
cence microscopy. Where indicated, periodic acid-
Schiff (PAS) with and without preliminary di-
astase digestion and reticulum (Wilder) stains
were used.
7. Staining of tissue sections—The indirect im-
munofluoresconcc technic was used (11) and when
applicable the findings confirmed by the direct
technic.
Some cryostat-cut sections were washed with
buffered saline pH 7.5 for thirty minntes and then
treated for thirty minutes with the rabbit sernm
to be tested. The sections were then washed 5
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minutes X 4 with buffer following which fluores-
ccin conjugated goat antirabbit gamma globuhn
was applied for thirty minutes. The tissue sections
were again washed with buffer five minutes >< 4.
A coverslip was applied using Coon's buffered
glycerol as the mounting medium (12). The fol-
lowing controls for specificity of staining were
done:
1. A pre-immunization serum from each rabbit
was used as a control for tbe post-immuniza-
tion serum of tbe same rabbit.
2. Rabbit antiovalbumin serum and serum from
rabbits injected with Freund's adjuvant and
normal saline were used as controls.
Other sections were washed with Coon's buff-
ered saline pH 7.5 for thirty minutes and then
treated with fluorescein-conjugated rabbit antibu-
man malignant melanoma serum or fluorescein-
conjugated rabbit antihuman skin serum.
The following controls for specificity of staining
were done:
Tjnconjugated rabbit antihuman malignant mel-
anoma serum or unconjugated rabbit antibuman
skin serum was applied to the tissue sections for
two hours. The sections were washed for ten
minutes with two changes of buffer and then the
corresponding fluorescein-conj ugated rabbit anti-
serum was applied for thirty minutes.
After the final washing of the sections a cover-
slip was applied using Coon's buffered glycerol as
mounting medium. The tissue sections were ex-
amined under a Leitz Ortholux fluorescence micro-
scope using a 2 mm TIC I for UV light excitation
and a 2.5 mm Euphos barrier filter. Photographs
were taken using Kodak high speed Ektachrome
film for daylight. Exposure times varied from one
to four minutes.
8. Possice cutoieeous anophyloxis (13).—Serums
from rabbits injected with human malignant mela-
noma, human skin, human 7S gamma globulin and
normal saline were injected intradermally in 0.1
ml amounts at different sites 1 cm apart into the
backs of albino guinea pigs weighing about 250
grams. Two milliliter aliquots of Virtis homog-
enized emulsions (14 mg per ml) of human malig-
nant melanoma or human skin were mixed with
0.5 ml of a 1% Evans blue solution in 0.15 M
NaCl. Four hours after the intradermal injections
of the serums, four guinea pigs were injected with
the human skin and four guinea pigs were in-
jected with the human malignant melanoma emul-
sions intravenously. The injected skin sites were
observed for 45 minutes after the intravenons
challenge. The guinea pigs were then killed,
skinned and reactions measured on inner surface
of skin. Observations were made for localization of
dye.
RESULTS
The results of the staiuing reactions are listed
in Tables II, III and IV.
Rabbits immunized with tissue from human
malignant melanoma, human shin or human 78
gamma globulin developed serum antibodies
which were shown by the immunofluorescence
technic to react with: (a) stroma of malignant
melanoma tissue (Fig. 1), (b) cytoplasm of
plasma cells and/or large mononuclear cells
within the tumor (Fig. 2), (c) stroma sur-
rounding tubules in the human kidney (Fig. 3),
(d) basement membrane of renal glomerular
capillaries and Bowman's capsule (Fig. 4), (c)
walls of some blood vessels, (f) pars papillaris of
human skin, (g) scattered areas between dermal
collagen bundles. No significant localization of
antibodies in or on malignant melanoma tumor
cells occurred (Fig. 1). The route or duration
of injection did not significantly influence the
results obtained. There was no apparent differ-
ence in the staining pattern after immunization
of rabbits with leuman malignant melanoma,
normal human skin, or human gamma globulin.
Rabbits immunized with human albumin de-
veloped serum antibodies which were shown by
the immunofluoresccnce technic to stain those
sites listed above except that they did not stain
the cytoplasm of plasma cells and/or large
mononuclear cells.
Details of results of staining after tissue
powder absorptions arc given in Tables TI, III
and TV. Absorption of the antiscrums with hu-
man spleen abolished all specific green fluores-
cent staining seen on the tissue sections of hu-
man kidney, human malignant melanoma and
human skin. Absorption of antiscrums with
either beef liver or beef spleen did not diminish
the specific green fluorescent staining seen on
the above tissue sections.
When the ovalbumin or complete Freund's
adjuvant alone was injected into rabbits, the
serums did not show staining of kidney, skin or
malignant melanoma tissue except in the case
of rabbit antiovalbumin serum where equivocal
green fluorescence of the tumor cells occurred.
Six rabbits out of twelve who were injected with
human gamma globulin failed to develop anti-
human gamma globulin antibody detectable by
immunoclectrophoretic analysis or qualitative
prccipitin ring tests (14). These six serums did
not show any of the above staining characteris-
tics.
Post-immunization rabbit serums were sepa-
rated into 7S and non-7S fractions by DEAE
column chromatography. The 78 component of
serums of rabbits injected with human skin and
human malignant melanoma showed staining of
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TABLE II
Staining reactions of human malignant melanoma
Serum Cytoplasm offumoc cells
Cytoplasm of Stromaplasma and/ betweenor mono- tumor cellsnuclear cells
Antihuman malignant melanoma, antihuman skin or antihuman
gamma globulin serums
Antihuman albumin serum
Antiovalbumin serum
1+—N 4+
N
N
4+
2—3+
N
Antihuman malignant melanoma serum absorbed with:
1. Human kidney, spleen or lung
2. Human liver or human brain
3. Human plasma, gamma globulin or human blood cells
4. Human albumin, beef liver or beef spleen
N
N
N
N
N
N
N
4+
1—2+
3—4+
3—4+
Antihuman skin serum absorbed with:
1. Human spleen
2. Human lung or human kidney
3. Human liver
4. Human brain, plasma, gamma globulin or blood cells
5. Human albumin, beef liver or beef spleen
N
N
N
N
N
N
N
N
N
4+
N
1-2+
2-3+
3—4+
3—4+
Antihuman gamma globulin serum absorbed with:
1. Human kidney, spleen, lung, liver, brain or blood cells
2. Human gamma globulin
3. Human albumin or beef liver
N
N
N
N
1+—N
4+
N
1+
3—4+
Antihuman albumin serum absorbed with:
1. Human kidney, lung, or spleen
2. Human brain, albumin, or blood cells
3. Human plasma or human gamma globulin
4. Human liver, beef liver or beef spleen
N
N
1+
N
N
N
N
N
1—2+
1+-N
2—3+
Antihuman malignant melanoma serum after pretreatment with un-
labeled homologous serum or unlabeled antihuman skin serum
Antihuman malignant melanoma serum after pretreatment with un-
labeled normal rabbit serum
Normal Habbit Serum
N
N
N
4+
N
4+
N
Code:
N—No specific fluorescence; green fluorescence; 1—Minimal green fluorescence; 2—
Moderate green fluorescence; 3—Bright green fluorescence; 4—Brilliant green fluorescence.
stroma and mononuclear cells within malignant
melanoma tissue sections using both the direct
and indirect Coon's technics; whereas the non-
7S component showed no staining by these
methods. The 7S component of serums of rab-
bits injected with human gamma globulin did
not show stromal staining; however, mononu-
clear cells were stained.
The staining of the cytoplasm of plasma cells
and/or large mononuclear cells within the tu-
mor could be eliminated by prior absorption of
the serums with human gamma globulin. The
staining of these cells was blocked by prior
treatment of the tissue section with unconju-
gated rabbit antihuman gamma globulin.
Heating the serums at 56° C for thirty min-
utes did not affect the above reactions, nor did
prior treatment of tissue sections with hyalu-
ronidasc.
The results of the passive cutaneous anaphy-
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TABLE III
Staining reactions of human kidney
Serum
Glumerular
basement
membrane
3-4+
N
Stronia
around
tubules
3—4+
N
Walls of
blood
vessels
3—4+
N
Antihuman malignant melanoma, antihuman skin, antihuman gamma
globulin or antihuman albumin serums
Antiovalbumin serum
Antihuman malignant melanoma serum absorbed with:
1. Human spleen
2. Human kidney, lung or liver
3. Human brain
4. Human gamma globulin, albumin, blood cells, plasma, beef liver
or beef spleen
N
N
N
3—4+
N
N
2+
3—4+
N
3+
N
3—4+
Antihuman skin serum absorbed with:
1. Human spleen
2. Human kidney or human lung
3. Human liver, plasma, gamma globulin, beef liver or beef spleen
4. Human brain, blood cells or albumin
N
N
3—4+
3—4+
N
N
3—4+
3—4+
N
1—2+
3—4+
1—2+
Antihuman gamma globulin serum absorbed with:
1. Human spleen or human brain
2. Human kidney, lung or liver
3. Human blood cells
4. Human gamma globulin, human albumin or beef liver
N
N
1—2+
3—4+
N
N
1+
3—4+
N
2-3+
2—3+
3—4+
Antihuman albumin serum absorbed with:
1. Human spleen
2. Human kidney, lung, or liver
3. Human brain
4. Human plasma, gamma globulin or albumin
4. Human blood cells
6. Beef liver or beef spleen
N
N
N
1—2+
3+
3—4+
N
N
2-3+
N
N
4+
N
2—3+
N
2—3+
2+
3+
Antihuman malignant melanoma serum after pretreatment with un-
labeled homologous serum or unlabeled antihuman skin serum
—1--
Antihuman malignant melanoma serum after pretreatment with Un-
labeled normal rabbit serum
4+ 4+ 4+
Normal rabbit serum N N N
Code:
N—No specific fluorescence; green fluorescence; 1—Minimal green fluorescence;
2—Moderate green fluorescence; 3—Bright green fluorescence; 4—Brilliant green fluorescence.
laxis experiment are listed in Table V. The read- prepared with rabbit antimalignant melanoma
ings represent the maximum diameters of dye at serums were not considered significant.
the injection sites.
The small differences between reactions in- DISCUSSION
duced by malignant melanoma and those in- An attempt was made to demonstrate specific
duced by human skin homogenates injected antibodies to elements of human malignant
intravenously into guinea pigs with skin sites melanoma tissue in the serums of rabbits in-
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TABLE IV
Specific staining reactions of human skin
serum Papillary layerof dermis
Ground substance
between collagen Elderm1s,east tiss,e
Antihuman malignant melanoma, antihuman skin, antihu-
human gamma globulin or antihuman albumin serums
Antiovalbumin
3—4+
N
3—4+
N
N
N
Antihuman malignant melanoma or antihuman skin serum
absorbed with:
1. Human spleen
2. Human plasma, beef liver or beef spleen
N
3—4+
N
3—4+
N
N
Antihuman albumin serum absorbed with:
1. Human spleen or human plasma
2. Beef liver or beef spleen
N
2—3+
N
2—3+
N
N
Code:
N—No specific fluorescence.
1—Minimal green fluorescence.
2—Moderate green fluorescence.
3—Bright green fluorescence.
4—Brilliant green fluorescence.
Code:
FITO = Fluorescein Isothiocyanate
GARGG Goat Anti-Rabbit Gamma Globulin
Fie. 1. Section of metastatic amelanotic malignant melanoma treated with post-im-
munization serum of a rabbit injected with human skin after which FITC conjugated
GARGG was applied. (Magnification X 169.) Shows: Stroma of tumor brilliant green.
Tumor cells show dull, non-specific green fluorescence.
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Fsa. 2. Section of metastatic amelanotic malignant melanoma treated with the post-
immunization serum of a rabbit injected with human malignant melanoma after which
FITC conjugated GARGG was applied. (Magnification X 169.) Shows: Brilliant green
fluorescence of stromal strands and cytoplasm of plasma and/or mononuclear cells. Tumor
cells (upper right hand corner) arc non-fluorescent.
Fie. 3. Section of human kidney treated with post-immunization serum of a rabbit in-jected with human malignant melanoma after which FITO conjugated GAROG was applied.
(Magnification >< 169.) Shows: Brilliant green staining of stroma of renal tubules.
Lur J,a
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FIG. 4. Section of human kidney treated with post-immunization serum of a rabbit in-jected with human malignant melanoma after which FITC conjugated GARGG was applied.
(Magnification >< 169.) Shows: Brilliant green staining of glomerular basement membrane.
TABLE V
Passive cutaneous anaphylaxis
Total number
Serums injected intradermally Reactions in millimeters*
Number of rabbits
in each group Human
malignant Human skin
melanoma
Type
10 Antihuman malignant melanoma 1
1
1
1
6
21
20
19
11
0
0
19
18
10
3
0
01 Antihuman skin 1
2 Antihuman gamma globulin 1
1
16
0
5
0
1 Antiovalbumin 1 0 0
1 Freund's adjuvant and normal saline alone 1 0
1 0
0
01 Normal rabbit serum
* Readings represent the average reading for 4 different guinea pigs in each experiment.
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jected with homogenates of the tumor tissue.
The following serum antibody reactions were
found by the immunofluorescence technic:
A.—Fluorescein conjugated rabbit antimela-
noma serum was found to stain the connective
tissue stroma of tissue sections of human malig-
nant melanoma. In order to determine if this
reaction was tumor specific, sections of normal
human skin and kidney were exposed to the
same antiserum. In normal human skin, stain-
ing occurred in the papillary layer of the der-
mis, in the stroma between collagen bundles and
in the stroma around adnexa. In human kidney,
the stroma surrounding renal tubules and base-
ment membrane of glomcrular capillaries and
Bowman's capsule specifically fluoresced. Rabbit
antihuman skin serum reacted in a manner
identical to the rabbit antimelanoma serum. It
was possible to block the stronml staining of
the conjugated antihuman malignant melanoma
serum by prior incubation of the tissue sections
with unconjugatcd rabbit antihuman skin serum.
Absorption of the antimelanoma serum with
normal human spleen, lung, or kidney removed
the stromal staining. Using the indirect Coon's
technic, rabbit antihuman albumin and anti-
human gamma globulin showed the same pattern
of staining as rabbit antihuman skin and anti-
human melanoma serum; however, the staining
was of less intensity. Contrary to the finding
with antihuman skin and antihuman melanoma
serums, when the antihuman albumin and anti-
gamma globulin serums were directly conju-
gated with fluorcsccin isothiocyanate, this stain-
ing was lost. This may be due to the fact that
a component of rabbit serums other than 7S
gamma globulin was responsible for the stain-
ing and that this component was detected using
conjugated goat antirabbit gamma globulin.
The goat antirabbit gamma globulin used was
shown by immunoelectrophoretic analysis to
possess antibodies to components of rabbit serum
other than 7S gamma globulin. It is also possible
that the factor was diluted out during the con-
jugation procedure. Milazzo (15) demonstrated
by preeipitin tests that antiserum to human
globulin reacted with human glomerular anti-
gen. Tan and Kaplan (16) found that antiserum
to a fraction of mouse serum beta-globulin was
found reactive by the immunofluorescence tech-
nique with basement membrane of renal gb-
meruli and tubules and with basement membrane
and connective tissue in other organs.
The above findings reveal that the staining of
stroma was not tumor specific; they suggest an
immunologic relationship of cutaneous, renal
and malignant melanoma stromal antigens.
B .—Tbe walls of blood vessels stained in tis-
sue sections of human kidney, human skin and
human malignant melanoma when these were
incubated with either rabbit antihuman mela-
noma, antibuman skin, antihuman gamma globu-
lin, or antihuman albumin serums. This staining
was best absorbed out by human brain or
spleen powder. The exact site of staining or
type of vessels stained could not be precisely
determined. Cruickshank and Hill described
similar staining of blood vessel walls with anti-
serums prepared against renal connective tissue
(17, 18).
C.—Conjugated rabbit antihuman malignant
melanoma serum stained the cytoplasm of
plasma cells and/or large mononuclear cells
within the tumor tissue. These cells were also
stained by conjugated rabbit antihuman skin
and rabbit antihuman gamma globulin serum.
On immunoelcctrophoresis all these serums were
shown to possess an antihuman gamma globulin
antibody. Absorption of the antiserums with
either human gamma globulin, plasma, spleen,
liver, kidney, lung, brain, or blood cells removed
the staining. They were not stained by conju-
gated rabbit antihuman albumin or antioval-
bumin serum. Evidently the staining was due
to the presence of gamma globulin. While signifi-
cant amounts of gamma globulin were not
detectable in or on the tumor cells, 7 out of 13
human malignant melanomas showed the pres-
ence of gamma globulin in cells believed to be
plasma cells and/or large mononuclear cells.
While the gamma globulin in these cells may
have been sufficient to act as the antigen, other
sources within the tissues used for immuniza-
tion of the rabbits must be considered. Since
rather intense immunization schedules were
used, small amounts of gamma globulin in the
tissue spaces or intravaseularly may have pro-
voked the response. The fact that normal human
skin injected into rabbits resulted in the pro-
duction of antibodies to human gamma globulin
would favor the non-tumor specificity of this
finding.
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D.—.Neither conjugated rabbit antihuman
malignant melanoma serum nor the other anti-
serums studied significantly stained the cyto-
plasm of malignant melanoma tumor cells.
Virtually no information is available concern-
ing the threshold sensitivity of the immuno-
fluorescence technic. Passive cutaneous anaphy-
laxis, however, has been demonstrated to be a
sensitive procedure for the demonstration of
antigen-antibody reactions. With this method no
differences could be demonstrated when either
malignant melanoma or skin emulsions were in-
jected intravenously into guinea pigs with skin
sites prepared with rabbit antimalignant mela-
noma serums (Figs. 5 and 6). Thus, this inde-
pendent immunologic tool also failed to demon-
strate the presence of tumor-specific antigen in
human malignant melanoma.
The reasons why in this study attempts to
obtain antibody directed toward tumor cells
themselves failed is unknown; however, the fol-
lowing possibilities were considered:
1. Whole tumor homogenate has many potent
antigens and the rabbit may not have
been able to produce a detectable circulat-
ing antibody response to weaker antigens.
Therefore, if tumor specific antigens exist
and are weak antigens, the animals would
fail to respond to them.
2. The technies employed are incapable of
detecting any cell-bound antibody which
the rabbits might have produced.
3. The rabbit may not be the laboratory ani-
mal of choice for attempts to immunize
with tumor tissue (19).
4. Malignant melanoma may indeed, not pos-
sess a specific tumor antigen.
SUMMARY
1. Rabbits immunized with tissue from hu-
man malignant melanoma, human skin and
other control materials, developed serum anti-
bodies which were shown by the immunofluo-
rescenee technic to react with: (a) stroma of
malignant melanoma tissue; (b) cytoplasm of
plasma cells and/or large mononuclear cells
within the tumor; (e) stroma surrounding tu-
bules in human kidney; (d) basement mem-
brane of the renal glomeruli; (e) walls of some
blood vessels; (f) pars papillaris of human skin
and (g) scattered areas between dermal collagen
bundles.
2. The staining of the cytoplasm of plasma
cells and/or large mononuclear cells in 7 out of 13
human malignant melanomas studied was due
to the presence of gamma globulin. The signifi-
cance of this finding is unknown.
3. Attempts to demonstrate rabbit antibodies
specific for human malignant melanoma cells
were unsuccessful.
REFERENCES
1. Hiramoto, H. and Pressman, D.: Immuno-
histoehemieal staining properties of human
skin and some related tnmors. Cancer Res.,
17: 1135, 1957.
2. Blakemore, W. S. and MeKenna, J. M.: Anti-
bodies reactive with antigens derived from
HeLa and J-III in patients with malig-
nancies. Surgery, 52: 213, 1962.
3. Abramoff, P., Chiochinian, H. and Saunders,J. W. Jr.: Detection of antigenically dis-
tinctive components of mouse melanoma 5-
91. J. Nat. Cancer Inst., 22: 919, 1959.4. Conn, J. H. and Fain, W. R.: Immunological
studies with hamster melanoma. Surg. Fo-
mm, 10: 1, 1960.5. Makari, J. C.: Recent studies in the immu-
nology of cancer. II. Demonstration of anti-
bodies to cancer polysaceharides and to
polysaceharide-antibody complexes by an
intradermal reaction. J. Amer. Geriat. Soc.,
8: 4, 1960.
6. Mason, H. S., Peterson, E. W., Frisch, A. and
Karens, M.: Melanoma chemotherapy. I.
Some properties of antimelanin gamma
globulin. Cancer Res., 14: 648, 1954.7. Rosenberg, S. A. and Rosenberg, J. C.: In
Vivo and In Vitro demonstration of tumor
immunity to the transplanted melanoma of
hamsters. Fed. Proc., 20: 154, 1961.8. Vial, A. B. and Callahan, W.: The effect of
some tagged antibodies on human melano-
blastoma. Cancer, 10: 999, 1957.
9. Wilhclmj, C. M. Jr., Kierland, R. R. and
Owen, C. A. Jr.: Production of hypersensi-
tivity to skin in animals. Arch. Derm. (Chi-
cago), 86: 161, 1962.
10. Kopf, A. W., Silberbcrg, I. and Cooper, N. S.:
Immunohistochemical study of human ma-
lignant melanoma for the presence of gamma
globulin. J. Invest. Derm. 47: 83, 1966.
11. Weller, T. H. and Coons, A. H.: Fluorescent
antibody studies with agents of Varicella
and herpes zoster propagated in Vitro. Proc.
Soc. Exp. Biol. Med., 86: 789, 1954.
12. Coons, A. H. and Kaplan, M. H.: Locabzation
of antigen in tissue cells. II. Improvements
in a method for the detection of antigen by
means of fluorescent antibody. J. Exp. Med.,
91:1,1950.
13. Ovary, Z.: Immediate reactions in the skin of
experimental animals provoked by antibody-
antigen interaction. Progr. Allerg., 5: 459,
1958.
14. Kabat, E. A. and Mayer, M. M.: Experimen-
98 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
tal immunochemistry. 2nd ed., pp. 72, 642—
643. Springfield, Ill., Charles C Thomas, 1961.
15. Milazzo, S. C.: A study of the immunological
properties of Reticulin. J. Path. Bact., 73:
527, 1957.
16. Tan, B. M. and Kaplan, M. H.: Immunological
relation of basement membrane and a serum
beta globulin in the mouse. Demonstration
of renal basement membrane alteration in
mice injected with streptolysin S. Immunol-
ogy, 6: 331, 1963.
17. Cruickshank, B. and Hill, A. G. S.: The histo-
chemical identification of a connective-tissue
antigen in the rat. J. Path. Bact., 66: 283,
1953.
18. Hill, A. Q. S. and Cruickshank, B.: A study of
antigcnic components of kidney tissue. Brit.
J. Exp. Path., 34: 27, 1953.
19. Blaney, D. J., Rotte, T. C. and Silcr, V. E.:
Antigens in human malignant tissue and
development of antiserum in horses. Surg.,
Gynec., Obstct., 118: 341, 1964.
